1,668
Views
0
CrossRef citations to date
0
Altmetric
Neurology

Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom

ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, , , , , , , , , , , , , , ORCID Icon, ORCID Icon, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , & show all
Pages 109-125 | Received 28 Jul 2023, Accepted 07 Dec 2023, Published online: 26 Dec 2023